COMMUNIQUÉS West-GlobeNewswire

ProPhase Labs to Release Fiscal 2017 Results on Wednesday, March 21st

16/03/2018 - 15:23

DOYLESTOWN, Pa., March 16, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs (NASDAQ: PRPH ) announced today that financial results for the year ended December 31, 2017, will be released before the market opens on Wednesday, March [...]

Hydropothecary partners with Segra to scale-up production in preparation for cannabis legalization

16/03/2018 - 14:15

GATINEAU, Quebec, March 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSXV:THCX) (“Hydropothecary” or the “Company”) is pleased to announce its agreement with Segra International Corp. (“Segra”) to [...]

Hydropothecary s’associe à Segra pour intensifier la production en vue de la légalisation du cannabis

16/03/2018 - 14:15

GATINEAU, Québec, 16 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary » ou la « Société ») a le plaisir d’annoncer la conclusion d’une entente avec Segra International Corp [...]

Delcath Announces 2017 Financial Results

16/03/2018 - 14:00

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]

Tabula Rasa HealthCare to Exhibit and Present at APhA Annual Meeting and Exposition

16/03/2018 - 14:00

MOORESTOWN, N.J., March 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC ) a healthcare technology company optimizing medication safety by deploying new medication risk identification [...]

Bavarian Nordic Announces Partnership with U.S. Department of Defense to Combat Equine Encephalitis Virus

16/03/2018 - 13:55

Collaboration valued up to $36M Multivalent vaccine designed to protect humans against Eastern, Venezuelan, and Western equine encephalitis virus COPENHAGEN, Denmark, March 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC [...]

Zosano Reaches Enrollment Milestone in M207-ADAM Long-term Safety Study

16/03/2018 - 13:30

FREMONT, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Collegium to Present at Upcoming Investor Conferences

16/03/2018 - 13:06

CANTON, Mass., March 16, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the following investor conferences in March: The Oppenheimer & Company [...]

iCAD to Report Fourth Quarter and Fiscal 2017 Financial Results on Thursday, March 22, 2018

16/03/2018 - 13:00

NASHUA, N.H., March 16, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment [...]

Paratek Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference

16/03/2018 - 13:00

BOSTON, March 16, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD, will present at the upcoming 17th [...]

Akari Therapeutics To Report Fourth Quarter and Full Year 2017 Financial and Operational Results and Host Conference Call on March 21, 2018

16/03/2018 - 13:00

NEW YORK and LONDON, March 16, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan [...]

Progressive Care Reports 18% Increase in Year over Year Prescriptions Filled During February 2018

16/03/2018 - 13:00

MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces strong sales for the month of February 2018. PharmCo, LLC filled over 19,500 [...]

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

16/03/2018 - 13:00

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can be safely monitored rather than undergo prostate biopsy MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. ( [...]

Atara Biotherapeutics to Present at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)

16/03/2018 - 13:00

Post-transplant lymphoproliferative disorder (PTLD) following allogeneic hematopoietic cell transplant (HCT) is an aggressive disease impacting a young population and carrying a significant mortality rate in a [...]

Fortress Biotech Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights

16/03/2018 - 12:30

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results

16/03/2018 - 12:30

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today financial results for the [...]

Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference

16/03/2018 - 12:30

SAN DIEGO, March 16, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]

Xbrane Biopharma: Comment to call for an extraordinary general meeting

16/03/2018 - 12:02

Press release 2018-03-16 Xbrane Biopharma hereby calls for an extraordinary general meeting on Tuesday, April 3, 2018 at. 17.30 in Spårvagnshallarna, Birger Jarlsgatan 57 A, Stockholm. The reason for the call for [...]

Xbrane Biopharma AB: Notice of extra general meeting in Xbrane Biopharma AB

16/03/2018 - 12:01

Press release 2018-03-16 The shareholders of Xbrane Biopharma AB, reg. no. 556749-2375, (the "Company"), are hereby convened to an extra general meeting to be held on Tuesday 3 April 2018, at 17.30 p.m. at [...]